Replies to post #172536 on Amarin Corp Plc (AMRN)

[Don'tDrinkTheKoolAid]

That was the question I was asking just exactly how many people have DES? OK We now have the answer now how many are being treated for it with vascepa? It's hard enough getting it prescribed for on label uses, how many are using for off label DES COPD Alzheimers Cancer?
How will all those other uses be factored into a BO? How does a price get put on those on without any statistics?

[Don'tDrinkTheKoolAid]

An estimated 4.88 million Americans age 50 and older have dry eyes. Of these, over 3 million are women and 1.68 million are men.Aug 24, 2016

https://www.healthline.com/health/dry-eye/chronic-dry-eyes-statistics-facts-and-you#1

[biowreck]

JL...Des market has plenty of competitors already. I’ve been on V for years now...and guess what...I still got Des. I got V offlabel originally to treat arthritis in my joints...guess what...I still got joint pain. So for me, those two markets aren’t going to be that lucrative. But as for cardio treatment, that’s the prize right?